Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block

September 27, 2023 updated by: Samsun University

Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block in Knee Arthroplasty Patients Under Spinal Anesthesia: A Retrospective Cohort Study

In our clinic, routine suprainguinal fascia iliaca block (SIFIB) has been administered for postoperative analgesia in patients undergoing knee arthroplasty. Recently, we have introduced the IPACK (Infiltration between the Popliteal Artery and Capsule of the Knee) block to this regimen, and the aim of this retrospective study is to determine whether the addition of the IPACK block enhances the quality of analgesia.

Knee arthroplasty, also known as knee joint replacement surgery, is a common procedure performed to alleviate pain and improve joint function in patients with knee osteoarthritis or other knee-related conditions. Postoperative pain management is crucial for patient comfort and overall recovery.

In this study, we aimed to compare the two techniques mentioned earlier, namely the SIFIB (Suprainguinal Fascia Iliaca Block) and the SIFIB+IPACK, by examining the data of patients who underwent knee arthroplasty under spinal anesthesia at our clinic between January 1, 2023, and September 1, 2023.

Study Overview

Detailed Description

The knee's nerve supply is intricately derived from branches originating from both the sacral plexus and lumbar plexus, as highlighted in previous studies. Nerves responsible for innervating the surgical field include the femoral nerve (FN), obturator nerve (ON), sciatic nerve (SN), and the lateral femoral cutaneous nerve (LFCN), which is a non-incisional source of pain resulting from tissue manipulation and tourniquet use. These nerves represent potential targets for perioperative pain management strategies. In addition to these nerves, there is ongoing research concerning infiltration techniques specifically targeting the posterior knee capsule, known as the Infiltration of the Posterior Capsule of the Knee (IPACK), which has been elucidated and continues to be a subject of investigation.

Study Type

Observational

Enrollment (Actual)

88

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Samsun, Turkey
        • Samsun University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

data of patients underwent total knee arthroplasty under spinal anesthesia between 01.01.2023 and 01.09.2023

Description

Inclusion Criteria:

  • Patients meeting the following criteria and whose postoperative follow-up forms were completed in full were included in the study
  • Patients underwent total knee arthroplasty (TKA)
  • ASA class I to III.
  • operated under spinal anesthesia
  • patient controlled analjgesia device was used for analgesia

Exclusion Criteria:

Patients whose data were inaccessible or had incomplete follow-up forms were excluded from the study to ensure the accuracy and reliability of our analysis.

  • PCA device problems in follow up in 24 hours
  • anesthesia plans were converted to general anesthesia
  • spinal anesthesia failure
  • peripheral blocks used other than protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
SIFIB
Patients who underwent SIFIB in knee arthroplasty patients under spinal anesthesia will be evaluated retrospectively in terms of opioid consumption and NRS scores.
Ultrasound guided Suprainguinal Fascia Iliaca Block for Knee Arthroplasty Patients
Those who were administered opioids with PCA as rescue analgesic in the postoperative analgesia plan on the selected dates will be included in the study.
Other Names:
  • PCA
SIFIB+IPACK
Patients who underwent SIFIB+IPACK blocks in knee arthroplasty patients under spinal anesthesia will be evaluated retrospectively in terms of opioid consumption and NRS scores.
Ultrasound guided Suprainguinal Fascia Iliaca Block for Knee Arthroplasty Patients
Those who were administered opioids with PCA as rescue analgesic in the postoperative analgesia plan on the selected dates will be included in the study.
Other Names:
  • PCA
Ultrasound guided IPACK (Interspace between the popliteal artery and capsule of the posterior knee ) Block for Knee Arthroplasty Patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Opioid consumption
Time Frame: 24 hours
Opioid consumption via PCA device
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NRS scores
Time Frame: 24 hours
NRS scores in different time frames. In a Numerical Rating Scale (NRS), patients are asked to circle the number between 0 and 10, that fits best to their pain intensity. Zero usually represents 'no pain at all' whereas the upper limit represents 'the worst pain ever possible'.
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hatice Kusderci, M.D., Samsun University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 3, 2023

Primary Completion (Actual)

September 15, 2023

Study Completion (Actual)

September 15, 2023

Study Registration Dates

First Submitted

September 15, 2023

First Submitted That Met QC Criteria

September 22, 2023

First Posted (Actual)

September 26, 2023

Study Record Updates

Last Update Posted (Actual)

September 29, 2023

Last Update Submitted That Met QC Criteria

September 27, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SIFIB+IPACK

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Analgesia

Clinical Trials on SIFIB (suprainguinal fascia iliaca block)

3
Subscribe